Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review of therapeutic drug monitoring of anticancer drugs part two – Targeted therapies

Published:2014-08 Issue:12 Volume:50 Page:2020-2036
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Widmer Nicolas^ORCID,Bardin Christophe,Chatelut Etienne,Paci Angelo,Beijnen Jos,Levêque Dominique,Veal Gareth,Astier Alain

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference221 articles.

1. Targeted cancer therapy;Sawyers;Nature,2004

2. Kinases as targets in the treatment of solid tumors;Giamas;Cell Signal,2010

3. Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia;Cortes;Leukemia,2009

4. Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?;Von Mehren;Cancer Treat Rev,2011

5. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results;Hughes;Blood,2006

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of novel triazole-urea hybrids and their antiproliferative activity against pancreatic cancer through suppression of eEF2K and induction of apoptosis;Journal of Molecular Structure;2024-09

2. Development of Simultaneous Drug Concentration Measurement Method Using an Automated Pretreatment Liquid Chromatography/Tandem Mass Spectrometry System for Therapeutic Drug Monitoring;Pharmaceutics;2024-08-28

3. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II;Critical Reviews in Oncology/Hematology;2024-08

4. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

5. Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS);Anti-Cancer Agents in Medicinal Chemistry;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3